Abstract
Inflammation and oxidative stress are synergistic partners in the etiopathogenesis of diverse diseases. Polyphenols, such as anthocyanins, are responsible for the regulation of the inflammatory process and activation of the endogenous antioxidant defense system. Anthocyanins modulate the level of inflammatory markers and exert an anti-inflammatory effect. Consequently, translating the research outcomes into clinical practice significantly contributes to the prevention and management of chronic diseases. The chapter summarizes the role of anthocyanins as anti-inflammatory and anti-oxidative molecules in both health and diseases. Anthocyanins downregulate pro-inflammatory markers in chronic disease and thus suppress inflammation as well as oxidative stress in inflammatory disorders. The chapter can help researchers and other healthcare professionals to understand the importance of anthocyanin use in chronic diseases.
Related Journals
Current Clinical Pharmacology
Recent Patents on CNS Drug Discovery (Discontinued)
Letters in Drug Design & Discovery
Current Pharmaceutical Analysis
Current Drug Delivery
Current Nanomedicine
Coronaviruses
Applied Drug Research, Clinical Trials and Regulatory Affairs
Drug Metabolism and Bioanalysis Letters
Anti-Cancer Agents in Medicinal Chemistry
Related Books
Medical Applications of Beta-Glucan
Postbiotics: Science, Technology and Applications
Evidence-Based Research in Ayurveda against COVID-19 in Compliance with Standardized Protocols and Practices
Pharmaceutical Chemistry and Production: An Introductory Textbook
Pharmaceuticals for Targeting Coronaviruses
New Findings from Natural Substances
Nanopharmacology and Nanotoxicology: Clinical Implications and Methods
Practice and Re-Emergence of Herbal Medicine
New Avenues in Drug Discovery and Bioactive Natural Products
Plant-derived Hepatoprotective Drugs